Anticoagulant counter ion impact on bioanalytical LC-MS/MS assay performance: Additional validation required?

Bioanalysis

Volumn 3, Issue 21, 2011, Pages 2389-2391

  Sennbro, Carl Johan ^a   Knutsson, Magnus ^b   Timmerman, Philip ^c   Van Amsterdam, Peter ^d  

^a Active Biotech Research AB   (Sweden)

^b Ferring Pharmaceuticals AS   (Denmark)

^c JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^d Chemical Design and Synthesis Unit   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; ANTICOAGULANT AGENT; COUNTERION; DRUG ADDITIVE; LITHIUM ION; POTASSIUM ION; SODIUM ION;

AMMONIA BLOOD LEVEL; ANALYTIC METHOD; BLOOD SAMPLING; HUMAN; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; LITHIUM BLOOD LEVEL; POTASSIUM BLOOD LEVEL; REVIEW; SODIUM BLOOD LEVEL; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS; VALIDATION STUDY;

ANTICOAGULANTS; BLOOD CHEMICAL ANALYSIS; HUMANS;

EID: 81055133495     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.11.240     Document Type: Review

References (9)

1. US FDA.Center for Drug Evaluation and Research.Center for Veterinary Medicine.Guidance for Industry - Bioanalytical Method Validation (2001).
2. European Medicines Agency Committee for Medicinal Products for Human Use (CHMP).Guideline on Bioanalytical Method Validation (2011).
3. Viswanathan CT, Bansal S, Booth B et al.Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand-binding assays.Pharm.Res.24, 1962-1973 (2007). (Pubitemid 47389236)
4. Savoie N, Booth BP, Bradley T et al.The 2nd Calibration and Validation Group workshop on recent issues in good laboratory practice bioanalysis. Bioanalysis 1(1), 19-30 (2009).
5. Sennbro CJ, van Amsterdam P, Timmerman P et al.Comparison of anticoagulant counterion impact on bioanalytical LC-MS/MS assays; results from surveys within European Bioanalysis Forum.Bioanalysis 3(21), 2393-2399 (2011).
6. Bergeron M, Bergeron A, Furtado M et al.Impact of plasma and whole-blood anticoagulant counterion choice on drug stability and matrix effects during bioanalysis.Bioanalysis 1, 537-548 (2009).
7. Marcelín-Jiménez G, Angeles-Moreno AP, Contreras-Zavala L et al.A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.Clin.Ther. 31(9), 2002-2011 (2009).
8. Abbott R, Gordon B, van Amsterdam P et al.Conference report: from challenges to solutions.Bioanalysis 3, 833-838 (2011).
9. Sennbro CJ (on behalf of European Bioanalysis Forum).Choice of anticoagulant and comparison of counterions - results from two European Bioanalysis Forum surveys.Presented at: The EBF Open Symposium.Barcelona, Spain, 2 December 2010.